Tenet Healthcare Raises FY2026 Adj EPS Guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 Est; Narrows FY2026 Sales Guidance from $21.900B-$22.500B to $22.050B-$22.450B vs $22.351B Est
Benzinga Newsdesk 2 days ago
NewsGuidance
Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 analyst estimate. Narrows FY2026 sales outlook from $21.900 billion-$22.500 billion to $22.050 billion-$22.450
Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 analyst estimate. Narrows FY2026 sales outlook from $21.900 billion-$22.500 billion to $22.050 billion-$22.450 billion vs $22.351 billion estimate.